Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity.
Mahabady MK, Mirzaei S, Saebfar H, Gholami MH, Zabolian A, Hushmandi K, Hashemi F, Tajik F, Hashemi M, Kumar AP, Aref AR, Zarrabi A, Khan H, Hamblin MR, Nuri Ertas Y, Samarghandian S. Mahabady MK, et al. Among authors: saebfar h. J Cell Physiol. 2022 May;237(5):2309-2344. doi: 10.1002/jcp.30751. Epub 2022 Apr 18. J Cell Physiol. 2022. PMID: 35437787 Review.
MicroRNAs regulating SOX2 in cancer progression and therapy response.
Mirzaei S, Saebfar H, Gholami MH, Hashemi F, Zarrabi A, Zabolian A, Entezari M, Hushmandi K, Samarghandian S, Aref AR, Ashrafizadeh M, Khan H. Mirzaei S, et al. Among authors: saebfar h. Expert Rev Mol Med. 2021 Sep 29;23:e13. doi: 10.1017/erm.2021.15. Expert Rev Mol Med. 2021. PMID: 34583803 Review.
Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance.
Ashrafizadeh M, Saebfar H, Gholami MH, Hushmandi K, Zabolian A, Bikarannejad P, Hashemi M, Daneshi S, Mirzaei S, Sharifi E, Kumar AP, Khan H, Heydari Sheikh Hossein H, Vosough M, Rabiee N, Kumar Thakur V, Makvandi P, Mishra YK, Tay FR, Wang Y, Zarrabi A, Orive G, Mostafavi E. Ashrafizadeh M, et al. Among authors: saebfar h. Expert Opin Drug Deliv. 2022 Apr;19(4):355-382. doi: 10.1080/17425247.2022.2041598. Epub 2022 Apr 3. Expert Opin Drug Deliv. 2022. PMID: 35152815
STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response.
Sadrkhanloo M, Entezari M, Orouei S, Ghollasi M, Fathi N, Rezaei S, Hejazi ES, Kakavand A, Saebfar H, Hashemi M, Goharrizi MASB, Salimimoghadam S, Rashidi M, Taheriazam A, Samarghandian S. Sadrkhanloo M, et al. Among authors: saebfar h. Pharmacol Res. 2022 Aug;182:106311. doi: 10.1016/j.phrs.2022.106311. Epub 2022 Jun 15. Pharmacol Res. 2022. PMID: 35716914 Review.
Crosstalk of miRNAs with signaling networks in bladder cancer progression: Therapeutic, diagnostic and prognostic functions.
Hashemi M, Arani HZ, Orouei S, Rostamnejad E, Ghorbani A, Khaledabadi M, Kakavand A, Tavakolpournegari A, Saebfar H, Heidari H, Salimimoghadam S, Taheriazam A, Entezari M, Khan H. Hashemi M, et al. Among authors: saebfar h. Pharmacol Res. 2022 Nov;185:106475. doi: 10.1016/j.phrs.2022.106475. Epub 2022 Oct 3. Pharmacol Res. 2022. PMID: 36202185 Review.
EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions.
Hashemi M, Arani HZ, Orouei S, Fallah S, Ghorbani A, Khaledabadi M, Kakavand A, Tavakolpournegari A, Saebfar H, Heidari H, Salimimoghadam S, Entezari M, Taheriazam A, Hushmandi K. Hashemi M, et al. Among authors: saebfar h. Biomed Pharmacother. 2022 Nov;155:113774. doi: 10.1016/j.biopha.2022.113774. Epub 2022 Oct 3. Biomed Pharmacother. 2022. PMID: 36271556 Free article. Review.
Advances in RNAi therapies for gastric cancer: Targeting drug resistance and nanoscale delivery.
Hashemi M, Aparviz R, Beickzade M, Paskeh MDA, Kheirabad SK, Koohpar ZK, Moravej A, Dehghani H, Saebfar H, Zandieh MA, Salimimoghadam S, Rashidi M, Taheriazam A, Entezari M, Samarghandian S. Hashemi M, et al. Among authors: saebfar h. Biomed Pharmacother. 2023 Dec 31;169:115927. doi: 10.1016/j.biopha.2023.115927. Epub 2023 Nov 24. Biomed Pharmacother. 2023. PMID: 38006616 Free article. Review.
Gold nanostructure-mediated delivery of anticancer agents: Biomedical applications, reversing drug resistance, and stimuli-responsive nanocarriers.
Entezari M, Yousef Abad GG, Sedghi B, Ettehadi R, Asadi S, Beiranvand R, Haratian N, Karimian SS, Jebali A, Khorrami R, Zandieh MA, Saebfar H, Hushmandi K, Salimimoghadam S, Rashidi M, Taheriazam A, Hashemi M, Ertas YN. Entezari M, et al. Among authors: saebfar h. Environ Res. 2023 May 15;225:115673. doi: 10.1016/j.envres.2023.115673. Epub 2023 Mar 10. Environ Res. 2023. PMID: 36906270 Review.
The pharmacological and biological importance of EZH2 signaling in lung cancer.
Entezari M, Taheriazam A, Paskeh MDA, Sabouni E, Zandieh MA, Aboutalebi M, Kakavand A, Rezaei S, Hejazi ES, Saebfar H, Salimimoghadam S, Mirzaei S, Hashemi M, Samarghandian S. Entezari M, et al. Among authors: saebfar h. Biomed Pharmacother. 2023 Apr;160:114313. doi: 10.1016/j.biopha.2023.114313. Epub 2023 Feb 3. Biomed Pharmacother. 2023. PMID: 36738498 Free article. Review.
12 results